It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Serotonin is a key neurotransmitter involved in emotional regulation and memory. A number of studies using acute tryptophan depletion (ATD) in healthy subjects have shown that a temporary serotonin reduction both induces a negative emotional bias and impairs long-term memory. However, little is known about the specific effects of ATD on emotional memory. Using functional magnetic resonance imaging (fMRI), we investigated the effect of ATD on negative memory and executive function in healthy volunteers. Our emotional oddball task required participants to distinguish infrequently presented targets from distracting negative and neutral pictures. Memory for the distracting pictures was tested 1 h following the fMRI session. ATD selectively enhanced memory for negative distractors relative to neutral distractors and increased activation in response to the negative distractors in the left orbital-inferior frontal, dorsomedial prefrontal and bilateral angular gyri. ATD also induced greater activation in the left inferior frontal gyrus and anterior cingulate across all stimuli. Stronger frontal activation to distractors was positively correlated with memory performance on ATD but not control days, indicating a possible compensatory mechanism for coping with increased task demand under the ATD challenge. These findings highlight the importance of serotonin in negative memory with implications for mood disorders.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Brain Imaging and Analysis Center, 2 Department of Psychiatry and Behavioral Sciences, 3 Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, 4 Department of Psychology, Yale University, New Haven, CT, and 5 Department of Psychology and Neuroscience, Duke University, Durham, NC, USA; Brain Imaging and Analysis Center, 2 Department of Psychiatry and Behavioral Sciences, 3 Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, 4 Department of Psychology, Yale University, New Haven, CT, and 5 Department of Psychology and Neuroscience, Duke University, Durham, NC, USA
2 Brain Imaging and Analysis Center, 2 Department of Psychiatry and Behavioral Sciences, 3 Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, 4 Department of Psychology, Yale University, New Haven, CT, and 5 Department of Psychology and Neuroscience, Duke University, Durham, NC, USA